Kreative Organics is an API manufacturer based in India. It holds 8 active US drug master files and 4 valid CEPs across a filed portfolio of 10 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 2 May 2025 as VAI. Customs aggregates show $4.8M of exports covering 76 molecules to 20 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Hyderabad, India | 3003447972 |
| Molecule | Regulators | Docs |
|---|---|---|
| Bisacodyl | EDQM, US FDA | 2 |
| Etodolac | EDQM, US FDA | 2 |
| Choline Salicylate | US FDA | 1 |
| Diclofenac | US FDA | 1 |
| Ferric Carboxymaltose | US FDA | 1 |
| Glipizide | US FDA | 1 |
| Hydroxyzine | EDQM | 1 |
| Methenamine | US FDA | 1 |
| Salsalate | US FDA | 1 |
| Sodium Picosulfate | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | 1 | None |
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $586K | 9 |
| 2025 | Not reported | $4.8M | 20 |
| 2024 | Not reported | $4.1M | 27 |
| 2023 | Not reported | $4.7M | 21 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Kreative Organics comes back tiered against every other supplier able to file there.
Start for free